Although the regulation mechanism of various ion transporters is complicated (19), studies have demonstrated that the expression of SLC26A6 and Cl− transporting activity are upregulated in the type 2 diabetic heart model, which reveals that effective SLC26A6 blockers may be efficient in regulating pH of type 2 diabetic hearts (122). Here, SLC26A6 is linked to type 2 diabetes mellitus.